The company
Sarepta Therapeutics, Inc.
SRPT · Nasdaq
SRPT stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 5.5% below that average now. Biotechnology: 17% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Rotation
- Setting up
- Weeks in an uptrend
- out for 4
- Industry in uptrend
- 17% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $541K
- Officials’ trades on record
- 22
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
22 disclosed lines: House 18, Senate 0, executive 4; 6 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 4 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 14 Apr 2025filed 6 May 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 14 Jul 2023filed 21 Aug 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 13 Jun 2023filed 11 Jul 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $15k–$50k | 10 Apr 2023filed 19 May 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 6 Mar 2023filed 20 Apr 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | bought | $15k–$50k | 6 Mar 2023filed 17 Apr 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $1k–$15k | 31 Jan 2023filed 24 Feb 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | sold | $1k–$15k | 6 Nov 2020filed 9 Dec 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Stephen MayoDirector | sold | 7,239at $17.02 | 12 Mar 2026filed 13 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.